DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 58 filers reported holding DICERNA PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $534,000 | -27.3% | 35,000 | -41.7% | 0.01% | -28.6% |
Q2 2018 | $735,000 | -7.7% | 60,000 | -28.0% | 0.01% | -22.2% |
Q1 2018 | $796,000 | -41.2% | 83,300 | -44.4% | 0.01% | -40.0% |
Q4 2017 | $1,354,000 | +39.9% | 149,900 | -10.9% | 0.02% | +36.4% |
Q3 2017 | $968,000 | +227.0% | 168,300 | +80.4% | 0.01% | +175.0% |
Q2 2017 | $296,000 | -6.6% | 93,300 | 0.0% | 0.00% | 0.0% |
Q1 2017 | $317,000 | +17.8% | 93,300 | 0.0% | 0.00% | 0.0% |
Q4 2016 | $269,000 | -51.0% | 93,300 | 0.0% | 0.00% | -50.0% |
Q3 2016 | $549,000 | +92.0% | 93,300 | +75.0% | 0.01% | +60.0% |
Q1 2016 | $286,000 | -61.9% | 53,300 | -15.8% | 0.01% | -64.3% |
Q4 2015 | $751,000 | +44.4% | 63,300 | 0.0% | 0.01% | +27.3% |
Q3 2015 | $520,000 | -17.2% | 63,300 | +40.7% | 0.01% | -8.3% |
Q2 2015 | $628,000 | -41.9% | 45,000 | 0.0% | 0.01% | -45.5% |
Q1 2015 | $1,081,000 | +45.9% | 45,000 | 0.0% | 0.02% | +29.4% |
Q4 2014 | $741,000 | – | 45,000 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RTW INVESTMENTS, LP | 2,005,238 | $16,463,000 | 5.12% |
Abingworth LLP | 945,757 | $7,755,000 | 4.53% |
RA Capital Management | 2,428,571 | $19,939,000 | 2.86% |
Omega Fund Management, LLC | 223,457 | $1,835,000 | 1.03% |
DAFNA Capital Management LLC | 123,500 | $1,014,000 | 1.01% |
Iguana Healthcare Management, LLC | 100,000 | $821,000 | 0.32% |
Cormorant Asset Management, LP | 245,000 | $2,011,000 | 0.32% |
Eventide Asset Management | 315,300 | $2,589,000 | 0.15% |
AWM Investment Company, Inc. | 80,000 | $657,000 | 0.13% |
Palo Alto Investors LP | 267,890 | $2,199,000 | 0.11% |